Saturday 7 November 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.

Revenue: +58.1%
EPS: +142.2%
Free cash flow: +43.5%

Quarter to September 2026, against a year earlier

94.01 5.67 +6.42%

Follow KNSA

Alert me

Market cap: $6.9B
P/E: 65.9×
Fwd P/E: 67.8×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	52.34	59.77	49.13	51.56	+8 more quarters Free account
P/S ratio Full definition →	6.17	5.90	4.89	4.52
P/FCF ratio Full definition →	29.57	27.12	22.42	22.42
P/Operating CF Full definition →	122.70	105.12	73.39	56.79
P/B ratio Full definition →	8.21	7.58	6.08	5.39
Price to Tangible BV Full definition →	8.39	7.76	6.24	5.54
EV/Sales Full definition →	5.57	5.27	4.27	3.91
EV/EBITDA Full definition →	39.78	43.46	33.89	33.60
EV/Operating CF Full definition →	26.48	23.98	19.39	19.18
EV/FCF Full definition →	26.69	24.25	19.57	19.39
Quick Ratio Full definition →	3.12	3.21	3.14	3.09
Current Ratio Full definition →	3.91	3.90	3.79	3.79
Net Debt/EBITDA Full definition →	(10.39)	(19.01)	(15.74)	(20.46)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	1.12	1.08	1.06	1.01
Operating CF/Net income Full definition →	1.00	1.86	2.22	3.80
Capex/Depreciation Full definition →	(0.37)	(1.40)	(0.34)	(1.36)
Research and Development Expense of Revenue Full definition →	11.46%	16.79%	12.82%	17.12%
Selling, General and Administrative Expense of Revenue Full definition →	22.86%	26.22%	28.54%	28.09%
Intangible Assets out of Total Assets Full definition →	0.01	0.02	0.02	0.02
Share Based Compensation of Revenue Full definition →	4.57%	4.78%	4.69%	5.06%
Graham Net Nets Full definition →	0.08	0.09	0.10	0.11
Graham Number Full definition →	17.07	14.25	13.21	11.73
Earnings Yield Full definition →	1.91%	1.67%	2.04%	1.94%
Free Cash Flow Yield Full definition →	3.38%	3.69%	4.46%	4.46%
Revenue per Share Full definition →	3.66	3.14	2.80	2.72
Operating CF per Share Full definition →	0.61	0.61	0.66	0.73
Capex per Share Full definition →	0.00	(0.01)	0.00	(0.01)
Free Cash Flow per Share Full definition →	0.61	0.60	0.65	0.72
Cash per Share Full definition →	7.27	6.78	6.12	5.58
Shareholders Equity per Share Full definition →	9.08	8.43	7.92	7.65
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	9.08	8.43	7.92	7.65
Free Cash Flow Full definition →	47.37	46.53	50.04	53.26
Working Capital Full definition →	558.24	497.39	437.56	387.99
Capital Expenditures Full definition →	(0.18)	(0.66)	(0.16)	(0.63)
Net Current Asset Value Full definition →	477.05	426.67	374.58	331.15
EV/EBIT Full definition →	40.36	44.24	34.50	34.27
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	44.72	49.49	39.52	39.64
Other line items
Average Receivables Full definition →	41.26	27.70	31.64	28.66
Average Payables Full definition →	5.13	10.68	13.19	2.03
Average Inventory Full definition →	74.71	59.56	47.61	40.63
Average Assets Full definition →	847.79	778.63	712.30	672.09
Average Common Equity Full definition →	622.79	574.58	531.59	503.02

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly